Erin McEvoy

In February, Senate Majority Leader Chuck Schumer explained in a press conference and in a letter to colleagues the details of his bill to federally legalize cannabis and announced his plan to introduce it in the coming weeks.

A dispensary in San Francisco, CA, joined with nearly two dozen cannabis brands, will donate proceeds starting on March 6 to support humanitarian aid in Ukraine.

Americans for Safe Access’s (ASA) State of the States report evaluates each state cannabis program from a patient perspective and assigns a grade that reflects patient rights and access to medical cannabis. ASA has released the report annually since 2014 and included two new core categories in the rubric for 2021. This year marks 25 years since the first implementation of a state cannabis law in the US and 20 years since ASA began working with state officials on medical cannabis laws.

The National Football League (NFL) is awarding $1 million in research funding to two teams of medical researchers to study the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players.

One of the largest companies in the world—Apple—quietly changed its policy regarding apps that handle the sale and delivery of cannabis.

MJH Life Sciences™ announces the acquisition of the Cannabis Science Conference, which hosts the world's largest and most technical scientific and medical cannabis events and is aimed at improving cannabis science and education.

Cannabis Science and Technology® is pleased to announce the addition of André Silva, MSc Forensic Science to its editorial advisory board (EAB).

The Cannabis Authenticity and Purity Standard (CAPS) announced Kim Stuck, founder of Allay Consulting, LLC, as its first certified cannabis and hemp consultant in the US.

Register now for a virtual symposium with presentations on Building a Cannabis Lab, Product Safety, Product Quality, Best Practices and Advanced Topics, and an interactive Certificate-Based Cannabis Testing Master Class session.

Endosane Pharmaceuticals and the University of California Irvine agree to conduct a set of studies to investigate the efficacy of new compounds for the treatment of PTSD.

Royal Emerald Pharmaceuticals, a leading cannabis pharmaceutical company, announced it has received four licenses from the DEA to grow, research, develop, and manufacture alternative drugs derived from cannabis and other botanicals.

Yissum, the Technology Transfer Company at Hebrew University of Jerusalem as well as the university's Multidisciplinary Center for Cannabinoid Research (MCCR) recently announced a new partnership with TechforCann Europe Accelerator to strengthen the medical cannabis industry in Europe.